AQR Capital Management’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.17M Buy
189,124
+102,416
+118% +$1.35M ﹤0.01% 2295
2025
Q4
$1.31M Buy
86,708
+53,144
+158% +$811K ﹤0.01% 2400
2025
Q3
$491K Buy
33,564
+14,214
+73% +$187K ﹤0.01% 2823
2025
Q2
$216K Sell
19,350
-1,059
-5% -$13.1K ﹤0.01% 3012
2025
Q1
$333K Buy
20,409
+8,241
+68% +$145K ﹤0.01% 2642
2024
Q4
$212K Sell
12,168
-8,411
-41% -$146K ﹤0.01% 2653
2024
Q3
$321K Sell
20,579
-11,284
-35% -$181K ﹤0.01% 2364
2024
Q2
$423K Buy
31,863
+1,336
+4% +$18.3K ﹤0.01% 2125
2024
Q1
$443K Buy
30,527
+249
+0.8% +$3.44K ﹤0.01% 1999
2023
Q4
$408K Sell
30,278
-51
-0.2% -$599 ﹤0.01% 1964
2023
Q3
$390K Buy
30,329
+9,831
+48% +$177K ﹤0.01% 1934
2023
Q2
$370K Sell
20,498
-51,838
-72% -$968K ﹤0.01% 1874
2023
Q1
$1.21M Sell
72,336
-104,842
-59% -$2.05M ﹤0.01% 1471
2022
Q4
$3.64M Buy
177,178
+95,851
+118% +$1.69M 0.01% 1022
2022
Q3
$1.55M Buy
81,327
+47,602
+141% +$1.07M ﹤0.01% 1312
2022
Q2
$794K Sell
33,725
-17,470
-34% -$500K ﹤0.01% 1511
2022
Q1
$1.67M Sell
51,195
-6,728
-12% -$216K ﹤0.01% 1291
2021
Q4
$1.8M Sell
57,923
-214
-0.4% -$7.15K ﹤0.01% 1236
2021
Q3
$2.22M Sell
58,137
-8,546
-13% -$340K ﹤0.01% 1083
2021
Q2
$2.67M Buy
66,683
+402
+0.6% +$17K ﹤0.01% 1069
2021
Q1
$2.87M Buy
66,281
+14,164
+27% +$624K ﹤0.01% 1018
2020
Q4
$2.24M Buy
52,117
+2,870
+6% +$105K ﹤0.01% 1117
2020
Q3
$1.53M Sell
49,247
-14,882
-23% -$462K ﹤0.01% 1219
2020
Q2
$2.05M Sell
64,129
-7,852
-11% -$261K ﹤0.01% 1154
2020
Q1
$2.02M Buy
71,981
+3,390
+5% +$131K ﹤0.01% 1074
2019
Q4
$3.17M Sell
68,591
-12,488
-15% -$587K ﹤0.01% 1103
2019
Q3
$4.3M Buy
81,079
+5,023
+7% +$259K 0.01% 1021
2019
Q2
$4.02M Sell
76,056
-7,872
-9% -$419K ﹤0.01% 1035
2019
Q1
$4.73M Sell
83,928
-2,695
-3% -$151K 0.01% 1002
2018
Q4
$4.55M Sell
86,623
-63,855
-42% -$3.63M 0.01% 975
2018
Q3
$8.7M Sell
150,478
-13,420
-8% -$752K 0.01% 832
2018
Q2
$9.31M Buy
163,898
+23,688
+17% +$1.35M 0.01% 810
2018
Q1
$8.24M Buy
140,210
+22,718
+19% +$1.27M 0.01% 830
2017
Q4
$6.43M Hold
117,492
0.01% 931
2017
Q3
$5.55M Sell
117,492
-22,050
-16% -$1.04M 0.01% 980
2017
Q2
$6.49M Sell
139,542
-9,751
-7% -$405K 0.01% 923
2017
Q1
$5.7M Buy
149,293
+7,123
+5% +$264K 0.01% 966
2016
Q4
$5.14M Sell
142,170
-138
-0.1% -$5.24K 0.01% 1033
2016
Q3
$6.09M Sell
142,308
-27,333
-16% -$1.22M 0.01% 926
2016
Q2
$7.19M Buy
169,641
+18,060
+12% +$785K 0.01% 799
2016
Q1
$6.29M Sell
151,581
-3,334
-2% -$131K 0.01% 813
2015
Q4
$6.07M Sell
154,915
-7,012
-4% -$262K 0.01% 855
2015
Q3
$5.46M Sell
161,927
-97,927
-38% -$3.49M 0.01% 790
2015
Q2
$8.61M Sell
259,854
-8,834
-3% -$304K 0.02% 658
2015
Q1
$9.64M Sell
268,688
-5,500
-2% -$173K 0.02% 555
2014
Q4
$8.24M Buy
+274,188
New +$8.04M 0.02% 731
2014
Q1
Sell
-263,100
Closed -$6M 2610
2013
Q4
$6M Buy
263,100
+22,104
+9% +$462K 0.02% 799
2013
Q3
$5.03M Sell
240,996
-48,500
-17% -$1.18M 0.02% 808
2013
Q2
$7.79M Buy
+289,496
New +$8.67M 0.03% 664

Other funds holding OFIX

AQR Capital Management's OFIX Position: Q1 2026 in Review

AQR Capital Management increased its Orthofix Medical (OFIX) stake by 118% in Q1 2026, buying an estimated $1.35M and bringing the position to 189,124 shares worth $2.17M. The position accounts for ﹤0.01% of the portfolio, ranked #2295.

AQR Capital Management first reported a position in OFIX in Q2 2013 and has held it in 49 quarters since. The position peaked at $9.64M in Q1 2015. 147 funds tracked by Wall St. Rank hold OFIX as of Q1 2026.

  • AQR Capital Management held 189,124 shares of Orthofix Medical worth $2.17M as of Q1 2026.
  • AQR Capital Management bought 102,416 Orthofix Medical shares in Q1 2026, an estimated $1.35M.
  • Orthofix Medical made up ﹤0.01% of AQR Capital Management's portfolio in Q1 2026, its #2295 holding.
  • AQR Capital Management first reported a position in Orthofix Medical in Q2 2013 and has held it in 49 quarters since.
  • AQR Capital Management's Orthofix Medical position peaked at $9.64M in Q1 2015.
  • 147 funds tracked by Wall St. Rank held Orthofix Medical as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.